FDA tied Jule's Foods' ready-to-eat vegan cashew brie to a multi-state Salmonella outbreak and cited insanitary conditions.
What happened
FDA inspected the Carlsbad, CA facility from April 21 to May 24, 2021 as part of a multi-state Salmonella outbreak investigation. FDA found matching Salmonella serotypes in environmental swabs, incoming raw organic cashew pieces, and ready-to-eat brie products; CDC and FDA determined the brie was the likely outbreak source. CDC reported 20 people infected from 4 states as of July 7, 2021.
What FDA found
FDA said the ready-to-eat vegan cashew brie was prepared, packed, or held under insanitary conditions that could make it harmful to health.
FD&C Act section 402(a)(4) (21 U.S.C. § 342(a)(4))FDA said the products contained Salmonella, a harmful substance that can make them injurious to health.
FD&C Act section 402(a)(1) (21 U.S.C. § 342(a)(1))FDA found Salmonella in incoming raw organic cashew pieces, and the company did not treat the cashews to eliminate it before use.
21 CFR 117.80(b)(2)FDA said the company had not submitted the required written statement that it identified hazards and applied preventive controls, or that it met state or local food safety law.
21 CFR 117.201(a)(2)FDA said a Salmonella-positive swab came from a table holding the mixer, and the company did not regularly clean that table.
FD&C Act section 402(a)(4) (21 U.S.C. § 342(a)(4))
What FDA wants
FDA asks Jule's Foods to correct the violations and send written steps, with supporting records, within 15 working days. FDA also asks for documentation of its Salmonella kill step and a hazard-control statement within 15 calendar days because FDA may withdraw the facility's modified requirements status.
Who should pay attention
- Retailers and distributors that sold ready-to-eat vegan cashew brie
- Food companies that buy raw nuts or cashews and rely on supplier certificates of analysis
- Contract manufacturers making ready-to-eat plant-based cheese or other high-risk foods
This is a summary. Read the original letter on fda.gov.